CHRS vs FTV · rev $26.6M vs P/E 31, rev $1.12B
Coherus BioSciences Inc (CHRS) versus Fortive Corp (FTV) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported FTV revenue for 2025-12-31 was $1.12B. Net income was $185.7M. Revenue was down 82.0% from 2024-12-31 to 2025-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
CHRS currently screens at market cap $223.7M. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Not investment advice. Open the CHRS and FTV stock pages for the full models.
Not investment advice.